Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.

Literature DB >> 21607042

Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.

D Gidaris¹, M Economou, V Hatzidemetriou, N Gombakis, M Athanassiou-Metaxa.

Abstract

Infantile haemangiomas are common benign tumours that do not require treatment unless they cause significant functional impairment or disfigurement. We report our experience with the off-label use of propranolol in 5 children with haemangiomas and review the relevant literature.

Entities: Chemical Disease Species

Keywords: beta-blocker; haemangioma; propranolol; vascular anomaly

Year: 2011 PMID： 21607042 PMCID： PMC3093152

Source DB: PubMed Journal: Hippokratia ISSN： 1108-4189 Impact factor: 0.471

Keyword Cloud
References

16 in total

1. Beta blockade induces apoptosis in cultured capillary endothelial cells.

Authors: Sally K Sommers Smith; Dennis M Smith
Journal: In Vitro Cell Dev Biol Anim Date: 2002-05 Impact factor: 2.416

2. More on propranolol for hemangiomas of infancy.

Authors: Elaine C Siegfried; William J Keenan; Saadeh Al-Jureidini
Journal: N Engl J Med Date: 2008-12-25 Impact factor: 91.245

3. PHACE syndrome: a constellation of cerebral and cardiovascular anomalies and segmental haemangiomas.

Authors: Chloe Stuttered; Elizabeth Carse; Arvind Sehgal
Journal: J Paediatr Child Health Date: 2009 Jan-Feb Impact factor: 1.954

4. Propranolol for severe hemangiomas of infancy.

Authors: Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal: N Engl J Med Date: 2008-06-12 Impact factor: 91.245

5. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.

Authors: Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Sarah L Chamlin; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Anthony J Mancini; Denise W Metry; Brandon Newell; Amy J Nopper; Ilona J Frieden
Journal: Pediatrics Date: 2006-09 Impact factor: 7.124

6. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.

Authors: G D'Angelo; H Lee; R I Weiner
Journal: J Cell Biochem Date: 1997-12-01 Impact factor: 4.429

Use of propranolol in infantile haemangiomas: report of five cases and review of the literature.

1. Beta blockade induces apoptosis in cultured capillary endothelial cells.

2. More on propranolol for hemangiomas of infancy.

3. PHACE syndrome: a constellation of cerebral and cardiovascular anomalies and segmental haemangiomas.

4. Propranolol for severe hemangiomas of infancy.

5. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.

6. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation.

7. Propranolol treatment for hemangioma of infancy: risks and recommendations.

Review 8. Propranolol treatment for infantile hemangiomas.

Review 9. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature.

10. Successful treatment of isolated subglottic haemangioma with propranolol alone.